Home > BIGG > Search result

    Results: 1

    Use of the Janssen (Johnson & Johnson) COVID-19 vaccine: updated interim recommendations from the advisory committee on immunization practices: United States, December 2021

    Oliver, Sara E; Wallace, Megan; See, Isaac; Mbaeyi, Sarah; Godfrey, Monica; Hadler, Stephen C; Jatlaoui, Tara C; Twentyman, Evelyn; Hughes, Michelle M; Rao, Agam K; Fiore, Anthony; Su, John R; Broder, Karen R; Shimabukuro, Tom; Lale, Allison; Shay, David K; Markowitz, Lauri E; Wharton, Melinda; Bell, Beth P; Brooks, Oliver; McNally, Veronica; Lee, Grace M; Talbot, H. Keipp; Daley, Matthew F.
    MMWR recomm. rep; 71 (3), 2022
    On February 27, 2021, the Food and Drug Administration (FDA) issued an Emergency Use Authorization (EUA) for the adenovirus-vectored COVID-19 vaccine (Janssen Biotech, Inc., a Janssen Pharmaceutical company, Johnson & Johnson), and on February 28, 2021, the Advisory Committee on Immunization Practices (A...
    Thrombosis/complications, Ad26COVS1/adverse effects, Immunization Programs/standards, COVID-19/prevention & control, Guillain-Barre Syndrome/complications
    Fulltext